The planned spinoff will allow for greater investment focus in the areas of “highest strategic priority” and help execute Medtronic’s leadership strategy in attractive medtech markets, the company said in an October.
Discussions with Carlyle Group, a private equity firm, have slowed, the report said. The devicemaker was looking to sell the businesses for about $10 billion.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
